Skip to main content
Professional Technical IVT

alpha-synuclein

Pronunciation: AL-fah sin-YOO-klee-in

A protein that forms pathological aggregates in Parkinson's disease and related synucleinopathies.

Full Definition

A presynaptic protein that, when misfolded and aggregated, forms the characteristic Lewy bodies and Lewy neurites seen in Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Alpha-synuclein pathology is the hallmark of synucleinopathies, distinct from tau and amyloid pathologies. Immunohistochemical staining for alpha-synuclein is essential for diagnosing these conditions and can reveal pathology not visible on routine H&E staining. The protein's normal function involves synaptic vesicle regulation, but its aggregated form is neurotoxic.

Usage

Usage note: Can be written as α-synuclein with Greek letter; distinguish from other protein aggregates in neurodegenerative diseases.

In Context

  • "Alpha-synuclein immunostaining revealed widespread Lewy body pathology." — neuropathology report
  • "The substantia nigra showed severe neuronal loss with α-synuclein aggregates." — autopsy findings

Also known as

α-synuclein synuclein

Don't confuse with

tau protein amyloid-beta

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON